# Dominik Andrzejczuk

> Dominik Andrzejczuk is a seed investor at Atmos Ventures backing Artificial Intelligence. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Atmos Ventures](https://shizune.co/investors/profile/atmos-ventures)
- Location: Palo Alto, United States
- Total investments: 2
- Last investment: Oct 2022
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/dominikand
- Facebook: http://www.facebook.com/domfaces

Dominik Andrzejczuk is a seed investor at Atmos Ventures in Palo Alto focused on Artificial Intelligence and Software. Dom has been involved in technology startups since the beginning of his professional career. He cofounded mobile payments startup Nooch, in 2010 and has since been involved in the fin tech vertical. Most recently, he was the Product Lead at the Virtual Currency startup Sohalo, where he established global relationships with Fortune 500companies, and developed the core social loyalty product. Dom holds a degree in Physics from Villanova University in Pennsylvania.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Artificial Intelligence | 2 | 100% |
| Software | 1 | 50% |
| Medical Device | 1 | 50% |
| Pharmaceutical | 1 | 50% |
| Machine Learning | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Poland | 1 | 50% |
| United Kingdom | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Solvemed Group | At Solvemed Group, we believe in challenging the status quo of neurological care. Our founders experienced first-hand the grave consequences of poor diagnostic standards in neurodegenerative diseases. With the primary focus in Parkinson’s disease, we leverage our proprietary machine learning technology to develop novel diagnostic-predictive digitalbiomarkers to enable first-in-class, accurate, early and cost-effective diagnostic and monitoring tools. In everything we do, we put the needs of patients and healthcare professionals first. We also happen to revolutionise drug discovery as our biomarkers enable disease-modifying drugs.We respond to the unmet needs of neurological patients by providing reliable, accurate, early diagnostics and monitoring tools for better quality care and treatment outcomes. Our work has the potential to improve healthcare systems by optimising relevant care pathways and reducing the financial burden imposed by inadequate diagnostics. Through our proprietary medical data repositories, we work with our biopharmaceutical industry partners driving clinical trial efficiency and making first-in-class disease-modifying drugs possible.Everything we do is strongly embedded in world-class science. Our global team of renowned scientists and technology experts works closely with clinical researchers from top research institutions, such as Oxford University, University College London, Harvard Medical School and Duke University, among other. | $3.6M | Seed | Oct 05, 2022 |  |
| Molecule.one | Molecule One is an information technology based bio company. Their m1 platform spans the preclinical pipeline to maximize chemistry. Molecule One integrates artificial intelligence into a suite of tools to assist bench chemists, data scientists, and computational chemists. | $4.6M | Seed | Jun 01, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [ff Venture Capital](https://shizune.co/investors/profile/ff-venture-capital) — VC Fund, 2 deals together
- [Sunfish Partners](https://shizune.co/investors/profile/sunfish-partners) — VC Fund, 2 deals together
- [AME Cloud Ventures](https://shizune.co/investors/profile/ame-cloud-ventures) — VC Fund, 1 deal together
- [APEX Ventures](https://shizune.co/investors/profile/apex-ventures-12df) — VC Fund, 1 deal together
- [APEX Ventures](https://shizune.co/investors/profile/apex-ventures-2) — VC Fund, 1 deal together
- [Cherubic Ventures](https://shizune.co/investors/profile/cherubic-ventures) — VC Fund, 1 deal together

## About Atmos Ventures

VC Fund · Palo Alto, United States

Atmos Ventures is focused on investing, nurturing, and growing Seed and Series A-stage European firms, as well as North American firms looking to open R&D centers in Europe, with a potential to become global players.Specifically, the Fund will be focusing on developing “deep technologies” for large enterprise applications, including:>A.I. & Machine Learning Commercial Solutions > Quantum Computing Enterprise Hardware & Software > Custom AI Hardware and Intelligent Processing Units > Next Generation Alternative EnergyHaving operated in positions of leadership in large enterprises, the Atmos management team has a strong understanding of the opportunities and challenges that exist in industry. Our approach is to offer unique new technologies to address these challenges, without disrupting internal workflows, putting us at the forefront of any enterprise’s digital transformation imperative.The Atmos management team'​ has wide-ranging, complimentary experience investing and/or scaling “deep tech” within investment firms and Fortune 500 enterprises.

3 contacts available at Atmos Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Sami Moughrabie | Managing Partner | https://shizune.co/investors/profile/sami-moughrabie |
| Dominik Andrzejczuk | Managing Partner | https://shizune.co/investors/profile/dominik-andrzejczuk |
| Hadi Solh | Managing Partner | https://shizune.co/investors/profile/hadi-solh |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Dominik Andrzejczuk invest in?

Dominik Andrzejczuk invests primarily in Artificial Intelligence, Software and Medical Device startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dominik Andrzejczuk last invest?

The most recent investment recorded for Dominik Andrzejczuk closed in Oct 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co